273 related articles for article (PubMed ID: 25555875)
1. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
2. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
3. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal.
Ren XF; Zhao H; Gong XC; Wang LN; Ma JF
Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929
[TBL] [Abstract][Full Text] [Related]
4. Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion.
Naz S; Ranganathan P; Bodapati P; Shastry AH; Mishra LN; Kondaiah P
Biochem J; 2012 Oct; 447(1):81-91. PubMed ID: 22747445
[TBL] [Abstract][Full Text] [Related]
5. USP4 promotes invasion of breast cancer cells via Relaxin/TGF-β1/Smad2/MMP-9 signal.
Cao WH; Liu XP; Meng SL; Gao YW; Wang Y; Ma ZL; Wang XG; Wang HB
Eur Rev Med Pharmacol Sci; 2016; 20(6):1115-22. PubMed ID: 27049265
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal.
Wang S; Li P; Jiang G; Guan J; Chen D; Zhang X
Bioengineered; 2020 Dec; 11(1):718-728. PubMed ID: 32619136
[TBL] [Abstract][Full Text] [Related]
7. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
8. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness.
Matsuura I; Lai CY; Chiang KN
Biochem J; 2010 Feb; 426(3):327-35. PubMed ID: 20070253
[TBL] [Abstract][Full Text] [Related]
9. S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.
Xie R; Schlumbrecht MP; Shipley GL; Xie S; Bassett RL; Broaddus RR
Lab Invest; 2009 Aug; 89(8):937-47. PubMed ID: 19506550
[TBL] [Abstract][Full Text] [Related]
10. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
11. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1 induced fascin1 expression facilitates the migration and invasion of kidney carcinoma cells through ERK and JNK signaling pathways.
Yang J; Zhang N; Gao R; Zhu Y; Zhang Z; Xu X; Wang J; Li Z; Liu X; Li Z; Li J; Bi J; Kong C
Biochem Biophys Res Commun; 2018 Jul; 501(4):913-919. PubMed ID: 29772238
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
[TBL] [Abstract][Full Text] [Related]
14. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
[TBL] [Abstract][Full Text] [Related]
15. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cells.
Mo N; Li ZQ; Li J; Cao YD
Asian Pac J Cancer Prev; 2012; 13(11):5709-14. PubMed ID: 23317243
[TBL] [Abstract][Full Text] [Related]
17. Targeting TGF-β1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2/9 signalling.
Zhang K; Liu X; Hao F; Dong A; Chen D
Am J Transl Res; 2016; 8(5):2196-209. PubMed ID: 27347327
[TBL] [Abstract][Full Text] [Related]
18. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
19. S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal.
Zhang W; Liu Y; Wang CW
Eur Rev Med Pharmacol Sci; 2014; 18(9):1361-7. PubMed ID: 24867514
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
